Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115706) titled 'Safety,efficacy and mechanisms of envolimab and S-1 systemic therapy combined with intraperitoneal endostar in the treatment of gastric/gastric-oesophageal junction adenocarcinoma with malignant ascites in elderly patients over 70 years' on Dec. 30, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Beijing Hospital
Condition:
gastric/gastric-oesophageal junction adenocarcinoma
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-02-19
Target Sample Size: Observational single-armd study:30;
Countries of Recruitment:
China
To know more, visit https:...